□ Synovial Sarcoma: Most cases express CD99, BCL-2, and TLE1 proteins, with molecular genetic analysis serving as a critical tool for distinguishing it from other soft tissue tumors. This evidence concerns the gene CD99 and soft tissue neoplasm.